Sintx Technologies (SINT) Stock Analysis & Winston Score
Sintx Technologies is a small medical materials company that makes products using silicon nitride, a tough ceramic material originally developed for industrial uses. The company focuses on using silicon nitride in medical implants, particularly spinal fusion devices, and is researching its use in antibacterial and antiviral applications. It sells to hospitals and surgical centers, primarily in the United States. Sintx makes money by selling its silicon nitride-based medical devices and through research partnerships and licensing agreements. The company is very small, with a market cap near zero and deeply negative profit margins, meaning it spends far more than it earns. Its main competitive angle is its specialized knowledge of silicon nitride ceramics, which few other companies work with in medical settings. The biggest risk the company faces is running out of cash before it can grow its product sales enough to become profitable, which is a serious concern given its current financial losses.
Winston Score: 22/100 — Weak
Weak fundamentals across most pillars.
- Quality: Weak (1/30)
- Growth: Good (10/20)
- Cash Flow: Weak (0/10)
- Stability: Weak (0/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
Key Facts
Price: $1.66
Market Cap: $7M
Sector: Healthcare
Industry: Medical - Devices
Exchange: NASDAQ Capital Market
